Improved detection of recurrent bladder cancer using the bard BTA stat test

By Sarosdy M.F.   Hudson M.A.   Ellis W.J.   Soloway M.S.   DeVere White R.   Sheinfeld J.   Jarowenko M.V.   Schellhammer P.F.   Schervish E.W.   Patel J.V.   Chodak G.W.   Lamm D.L.   Johnson R.D.   Henderson M.   Adams G.   Blumenstein B.A.   Thoelke K.R.   Pfalzgraf R.D.   Murchison H.A.   Brunelle S.L.  

Urology, Vol. 50, Iss. 3, 1997-09 ,pp. : 349-353

Elsevier

Access to resources Recommend Favorite

The authors have no affiliation with any of the biotechnology companies involved with the production and/or sales of the assays.Sensitivity and specificity of NMP-22, telomerase, and BTA in the detection of human bladder cancer - no end in sight

By Landman J.   Chang Y.   Kavaler E.   Droller M.J.   Liu B.C.-S.  

Urology, Vol. 52, Iss. 3, 1998-09 ,pp. : 398-402

Elsevier

Access to resources Recommend Favorite

Specificity of Human Complement Factor H-Related Protein Test (Bard BTA stat Test)

By Raitanen Mika P.   Tammela Teuvo L. J.  

Scandinavian Journal of Urology and Nephrology, Vol. 33, Iss. 4, 1999-09 ,pp. : 234-236

Informa Healthcare

Access to resources Recommend Favorite

Usefulness of the BTA stat Test for the diagnosis of bladder cancer

By Gutierrez Banos J.L.   del Henar Rebollo Rodrigo M.   Antolin Juarez F.M.   Garcia B.M.  

Urology, Vol. 57, Iss. 4, 2001-04 ,pp. : 685-689

Elsevier

Access to resources Recommend Favorite

Evaluation of nuclear matrix protein 22 (NMP22) as a tumor marker in the detection of bladder cancer

By Öge Ömer   Atsü Necmettin   Kendi Sezer   Özen Haluk  

International Urology and Nephrology, Vol. 32, Iss. 3, 2001-09 ,pp. : 367-370

Springer Publishing Company

Access to resources Recommend Favorite